Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus

Clinical Infectious Diseases

Volumn 23, Issue 5, 1996, Pages 990-995

  Alliegro, Maria Barbara ^a   Dorrucci, Maria ^b   Pezzotti, Patrizio ^b   Rezza, Giovanni ^b   Sinicco, Alessandro ^b   Barbanera, Mauro ^b   Castelli, Francesco ^b   Tarantini, Gloria ^b   Petrucci, Andrea ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; DISEASE COURSE; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLOW CYTOMETRY; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; INCIDENCE; INJECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION;

EID: 0029861919     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.5.990     Document Type: Article

References (15)

1. Fessel WJ. Early symptoms of human immunodeficiency virus infection [invited commentary]. Am J Epidemiol 1995;141:405-6.
2. Panda S, Sarkar S, Mandal BK, et al. Epidemic of herpes zoster following HIV epidemic in Manipur, India. J Infect 1994;28:167-73.
3. Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis 1988;157:314-8.
4. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. J Am Acad Dermatol 1986;14:1023-8.
5. Melbye M, Biggar RJ, Ebbesen P, et al. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med 1986;104:496-500.
6. Holmberg SD, Buchbinder SP, Conley LJ, et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol 1995;141:395-404.
7. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6.
8. van Griensven GJP, de Vroome EMM, de Wolf F, Goudsmit J, Roos M, Coutinho RA. Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men. Am J Epidemiol 1990;132:203-10.
9. Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster. Lancet 1987;1:728-31.
10. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow-up of the San Francisco General Hospital cohort. BMJ 1988;296:745-50.
11. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327:1697-703.
12. Glesby MJ, Moore RD, Chaisson RE, the Zidovudine Epidemiology Study Group. Herpes zoster in patients with advanced immunodeficiency virus infection treated with zidovudine. J Infect Dis 1993;168:1264-8.
13. Rogues A-M, Dupon M, Ladner J, Ragnaud J-M, Pellegrin J-L, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients [letter]. J Infect Dis 1993;168:245.
14. Eyster ME, Rabkin CS, Hilgartner MW, et al. Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value. Blood 1993;81:828-34.
15. Veenstra J, Krol A, van Praag RME, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995;9:1153-8.